Cordant Inc’s BioMarin Pharmaceuticals BMRN Stock Holding History

Cordant Inc’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$916	Hold	16	–	–	﹤0.01%	157
2026 Q1	$904	Hold	16	–	–	﹤0.01%	71
2025 Q4	$951	Buy	+16	New	+$871	﹤0.01%	66
2022 Q2	–	Sell	-25	Closed	-$2K	–	217
2022 Q1	$2K	Buy	+25	New	+$2.09K	﹤0.01%	591

Other funds holding BMRN

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Inspirion Wealth Advisors Libertyville, Illinois $873M AUM 16.23% 1-Year Est. Return

Miller Global Investments Dallas, Texas $121M AUM

Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return